Largest Biotechnology companies in United Kingdom by Market Capitalization

This ranking features the largest 46 Biotechnology companies in United Kingdom ranked by Market Capitalization, totaling a Market Capitalization of USD 337.40 B, for July 09, 2025.

#	Name	Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in United Kingdom has the highest Market Capitalization ?

The Biotechnology company in United Kingdom with the highest Market Capitalization is AstraZeneca PLC (LSE: AZN.L) at USD 220.20 B.

Which Biotechnology company in United Kingdom has the lowest Market Capitalization ?

The Biotechnology company in United Kingdom with the lowest Market Capitalization is Roquefort Therapeutics plc (LSE: ROQ.L) at USD 3.31 M.

What are the top 10 Biotechnology companies in United Kingdom by Market Capitalization ?

The top 10 Biotechnology companies in United Kingdom by Market Capitalization are AstraZeneca PLC, GSK plc, Smith & Nephew plc, Roivant Sciences Ltd., ConvaTec Group Plc, LivaNova PLC, Centessa Pharmaceuticals plc, Immunocore Holdings plc, Autolus Therapeutics plc and Advanced Medical Solutions Group plc.

What are the bottom 10 Biotechnology companies in United Kingdom by Market Capitalization ?

The bottom 10 Biotechnology companies in United Kingdom by Market Capitalization are Roquefort Therapeutics plc, Verici Dx plc, Cizzle Biotechnology Holdings Plc, GENinCode plc, Hemogenyx Pharmaceuticals Plc, Fusion Antibodies plc, Genedrive Plc, ImmuPharma plc, Proteome Sciences plc and Celadon Pharmaceuticals Plc.